25T-NBOMe, also known as 2C-T-NBOMe or NBOMe-2C-T as well as N-(2-methoxybenzyl)-4-methylthio-2,5-dimethoxyphenethylamine, is a serotonin 5-HT2 receptor agonist and possible serotonergic psychedelic of the phenethylamine, 2C, and 25-NB (NBOMe) families. It is the NBOMe (N-(2-methoxybenzyl)) derivative of 2C-T.

Interactions

Pharmacology

Pharmacodynamics

25T-NBOMe activities
TargetAffinity (Ki, nM)
5-HT1AND
5-HT1B3,385
5-HT1DND
5-HT1END
5-HT1FND
5-HT2A0.54 (Ki) 2.0–4.2 (EC50Tooltip half-maximal effective concentration) 86–179% (EmaxTooltip maximal efficacy)
5-HT2B0.91 (Ki) ND (EC50) ND (Emax)
5-HT2C7.4 (Ki) (rat) 21.4 (EC50) 103% (Emax)
5-HT3ND
5-HT4ND
5-HT5AND
5-HT6117
5-HT7ND
α1Aα1DND
α2Aα2CND
β1β3ND
D1D5ND
H1H4ND
M1M5ND
I1ND
σ1, σ2ND
ORsND
TAAR1Tooltip Trace amine-associated receptor 1ND
SERTTooltip Serotonin transporterND (Ki) ND (IC50Tooltip half-maximal inhibitory concentration) ND (EC50)
NETTooltip Norepinephrine transporterND (Ki) ND (IC50) ND (EC50)
DATTooltip Dopamine transporterND (Ki) ND (IC50) ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs:

25T-NBOMe acts as a potent agonist of the serotonin 5-HT2A and 5-HT2C receptors and also shows interactions with certain other targets, such as the serotonin 5-HT2B receptor.

History

25T-NBOMe was first described in the scientific literature by 2010.

Society and culture

Legal status

Canada

25T-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.

See also

External links